Depth bar (mandatory): Strategic listed Faridabad cluster. Target 2,500–4,000 words. Exhaustive subsections 1.1–6.3. Use [~] for estimates, [dir] for directories, [!] for unverified claims. Never invent bill numbers, court outcomes, or plant-head emails. ICP override for large listed: plant-scoped 60-Day Proof can proceed even when group procurement is slow — qualify the Faridabad HT, not the whole NSE entity, on day one.

1. Company overview & snapshot

Poly Medicure Limited (brand Polymed) is a listed Indian manufacturer of disposable medical devices — infusion therapy, renal, blood management, and a growing “others” bag that now includes cardiology and critical care. For Stamped’s Faridabad campaign the only sites that matter on the calendar are the DHBVN manufacturing plots in Ballabgarh / IMT: Sector 59 (104-105, 115-116, and 117 on later investor maps) and Sector 68 IMT plots 33-34 (IMT 1 and IMT 2). Okhla is the registered / communication office. Jaipur SEZ, Haridwar, Palwal (under construction), YEIDA land, and overseas plants (Italy, Netherlands, Egypt, China) are context, not this week’s walk.

The industrial logic is straightforward. High-volume injection moulding, automated assembly of cannula/IV sets, and ISO 7/8-class cleanroom HVAC with chillers, AHUs, compressed air, and water-for-injection / RO-DM loops sit on multiple HT incomers in one city. That is a utilities-heavy campus, not a warehouse. BRSR already publishes group energy in GJ and a 9.9 MWp AMPIN captive solar PPA. Stamped’s offer is assigned rupee actions on one Faridabad feeder, verified with evidence, not another sustainability slide.

1.1 Legal identity & corporate structure

FY26 IR consolidates PendraCare (from 23 Sep 2025) and Citieffe (from 7 Nov 2025), plus Brazil vehicle Medyneo. None of that changes the Faridabad DHBVN invoice name. Contracting entity must match the Haryana bill — almost certainly Poly Medicure Limited.

1.2 What they make & where money comes from

Core SKUs: IV cannulae, infusion sets, renal / dialysis consumables and machines, blood-management devices, and a long tail of surgery, anaesthesia, urology, and newer cardiology/critical-care lines. Investor decks cite 225+ devices, ~1.8 billion devices/year capacity, 125+ countries, 390+ patents, 1,000+ distributors. Treat capacity marketing as group-level, not Sector 59 throughput.

Money mix (consol):

Infusion therapy is still the largest slice (FY26 consol ₹997.3 Cr); renal ₹187.6 Cr; “Others” ₹690.4 Cr. Customers are hospitals and distributors globally — not auto OEMs. Energy still hits plant P&L: chillers do not care that the SKU is a cannula.

1.2a Scale, MSME status & trade (mandatory from Aug 2026)

1.3 Plants, addresses & footprint

Faridabad cluster (this campaign):

Out of Faridabad visit week: Haridwar 1 (commercially operational) and Haridwar 2; Jaipur SEZ 1 and 2; gamma sterilisation (captive, commercially operational — location confirm); YEIDA land near Noida airport (handover “expected soon” as of Mar 2026 IR); Amaro & Bologna (Italy), Leek (Netherlands), Assiut (Egypt), Laiyang-Qingdao (China).

IR machine counts are group: 400+ moulding machines, 1,800+ moulds & dies, 530+ automatic assembly machines, 130+ robots. Do not assign those counts to Sector 59 alone.

Pilot recommendation: One HT boundary — either the heavier Sector 59 incomer (cleanroom + moulding) or IMT if that plot’s bill is larger. Never a 15-plant SOW.

1.4 Leadership & CRM map — three champion types (mandatory)

Decision path: K.L. Gupta yes → Ramniwas / HVAC engineer executes → production/QA vetoes setpoint changes that touch validated processes → finance for bill copies → secretarial/legal if MSA. Himanshu is not first touch. CS Avinash Chandra (M.No. A32270) and IR inbox are routing, not plant P&L.

CFO in AR remuneration table: Naresh Vijayvergiya — later for bill-band, not cold outreach.

1.5 Recent news (24 months) & timing for Stamped

• FY25: Consol net sales ₹1,669.83 Cr (+21%), EBITDA ₹541.97 Cr, capex ₹325 Cr, QIP residual still large at 31 Mar 2025.
• FY26: Consol ₹1,875.3 Cr (+12.3%); standalone growth slower (+3.8%) while M&A (PendraCare, Citieffe) padded consol. Capex ₹296 Cr. ~8% Scope 2 reduction vs FY25 claimed via solar/PPA.
• Q1 FY26: Europe −6.7%; domestic +20.1% — do not open on “export boom.”
• Palwal end FY27 — not this Proof. Gamma commercially operational — ask if on a Faridabad meter.
• Stamp duty order (15 Jun 2026): Delhi Revenue ₹2.5 Cr; company contests. Not a plant-integrity story.

Timing: Sector 59 is on the LNM belt. Ask for plant utilities at 104-105 / 115-116; use investorcare only as labelled routing.

2. Energy profile

DISCOM / supply (name early): DHBVN (Dakshin Haryana Bijli Vitran Nigam) for Faridabad Sector 59 HSIIDC and IMT Sector 68. Palwal, when it commissions, is still Haryana DHBVN, not a UP DISCOM. Confirm consumer name, tariff (HT/EHT), sanctioned kVA, ToD, PF, and whether rooftop / AMPIN PPA alters marginal kWh vs MD.

2.1 Bill band, tariff & demand

No plant-level DHBVN invoice is in hand.

Working Faridabad cluster bill: ₹15–40 lakh/month [~] across Sector 59 + IMT plots. Single plot may sit in Band B; cluster may approach Band A. ₹30L+ Possible on cluster. Qualify meter-by-meter. Confidence: Medium.

BRSR FY24-25 group energy (not a Faridabad bill):

That electricity block is company reporting boundary, on the order of ~50–60 million kWh/year [~] if converted naively — do not divide by 12 and call it Sector 59. India manufacturing (Faridabad + Haridwar + Jaipur) is a large share of that, but overseas plants and sterilisation sit in the same tables. Use BRSR only to prove they already measure energy; use two redacted HT bills for ₹.

Inspect on first bills: contract vs billing demand, ratchet, ToD, PF incentive/penalty, whether chillers and moulding share an incomer, solar export/net metering.

2.2 Generation, fuel & renewables

• AMPIN C&I JV: Polymed 26%, AMPIN 74%, captive solar for Haryana manufacturing. BRSR: PPA tied to 9.9 MWp, projected ~28% Scope 2 cut when fully supplying (group claim). FY26 IR: ~8% Scope 2 reduction already vs FY24-25.
• Rooftop solar expanded (BRSR). Plot-level unknown.
• Dual-fuel DG and CNG vehicles named for Scope 1. DG backup typical — confirm run-hours.
• Fuel GJ jumped FY24→FY25 (16.5k → 40.3k) — ask what burned (PNG, diesel, LPG for WFI/steam) and which Faridabad plot.
• RE does not erase MD from coincident chiller + moulding starts.

2.3 EnMS, PAT, ISO, BRSR

• BRSR: Yes — FY23-24 and FY24-25. Energy tables, Scope 1/2, water, solar PPA.
• ISO 9001:2015, ISO 13485:2016, ISO 14001:2015 — public (BRSR principle mapping). FY26 IR: ~70% of facilities ISO 14001.
• ISO 50001: not found in AR, BRSR certifications list, or IR. Do not infer EnMS certification from ISO 14001.
• PAT DC: BRSR explicit No.
• Internal: “digital energy management tools” cited as avoiding ~120 tCO2e [BRSR] — treat as a monitoring experiment, not assigned rupee closure.

Stamped line: you already report GJ and buy solar — we turn recurring HVAC/moulding events into owned WhatsApp actions and keep them verified with evidence.

2.4 Likely ₹ leak categories (hypothesis)

Tied to med-device Faridabad, not auto:

1. Cleanroom HVAC / AHU / chiller running production setpoints through changeover, batch gaps, and second-shift underload — usually the kWh hog.
2. WFI / RO-DM / STP pumps and heat at night.
3. Injection-moulding coincident starts (400+ machines group-wide; local count unknown) creating MD with chillers already at peak.
4. Compressed air for assembly and packaging — leak + pressure setpoint.
5. Automated assembly idle (530+ machines group-wide).
6. ToD vs solar self-consumption mis-scheduling of non-validated loads.
7. Multi-plot blindness — group BRSR known; which Faridabad feeder owns the peak unknown.
8. Gamma / sterilisation if on a Faridabad incomer [?].

Each is a hypothesis for interval data + production calendar. Never propose dropping cleanroom differential pressure.

3. Operations, equipment & digital stack

3.1 Process flow & critical loads

Typical route: polymer / cannula incoming → injection moulding → cleanroom automated assembly (IV/cannula lines) → packaging → sterilisation (ETO / gamma — site-specific) → warehouse / export.

Critical electrical loads: chillers, AHUs, WFI/RO, compressors, moulding machines, assembly automation, HVAC for warehouses, packing. MD events: Monday / shift-open chiller recovery + multi-cell moulding starts. kWh: 24×7 cleanroom air.

K.L. Gupta profile mentions CNC [!] — toolroom, not the energy centre.

No public Yaskawa HT. Heat treatment is not this plant’s story.

3.1a Machine inventory (mandatory from Aug 2026)

Name what is publicly evidenced vs [~] vs unknown. Do not invent OEM counts for Sector 59.

If HT exists: it does not, on public evidence. Sterilisation heat is a different question (ETO vs gamma).

3.2 Shifts, seasonality, production pattern

Export + hospital demand implies multi-shift cleanroom. Validated processes mean weekend HVAC often stays live while output falls — false baseline risk. Normalise Proof to devices packed or standard hours, not calendar kWh. Q1 Europe dips do not automatically cut Faridabad HVAC.

3.3 Automation, metering, SCADA/EMS/DCS

High automation (robots, auto-assembly) implies cell PLC/HMI. Named plantwide EMS/SCADA vendor not public. BRSR “digital energy management tools” = some metering appetite. Path A if historian export exists; Path B = DHBVN CSV + chiller/moulding event log. No PLC writes. Cyber questionnaire likely for a listed med-device plant.

3.4 Capex / tech projects affecting energy

₹325 Cr FY25 + ₹296 Cr FY26 + QIP manufacturing spend + IMT expansion + Palwal FY27 + gamma facility. Post-capex, Stamped verifies operational capture of expected bill benefit rather than claiming the capex as its saving. Ask commissioning dates on the chosen Faridabad plot so the 60-Day Proof is not a construction mess.

4. Stamped Energy fit analysis

4.1 ICP scorecard

ICP override for large listed: Do not disqualify because IR exists. Qualify (a) Faridabad HT band, (b) K.L. Gupta sponsor, (c) bounded 60-Day Proof.

4.2 Fit score rationale

8/10 strategic / listed. Strengths: process intensity (HVAC + moulding), named plant head, named maintenance, verified IR emails, BRSR energy depth, local multi-plot campus, logo value. Deductions: enterprise cycle, bill unverified at plot level, solar PPA may shrink kWh faster than MD, change-control friction in a regulated plant, risk of conversation escaping to group digital / ESG.

4.3 Wedge (parser-critical)

The strongest wedge is: cleanroom HVAC / chiller / WFI continuous load plus injection-moulding and assembly coincidence on one Faridabad DHBVN HT (Sector 59 104-105/115-116 or IMT 33-34), turned into owned WhatsApp rupee actions and kept verified with evidence on Stamped’s ledger — complementing BRSR/solar work rather than replacing it.

4.4 Objections & competitors

Competitors: chiller OEMs, compressed-air vendors, ISO 14001 consultants, solar EPCs, internal digital-energy tools.

4.5 Pilot design

• Site: One Faridabad HT (prefer heavier of Sector 59 vs IMT).
• Scope: HVAC/chillers + moulding coincidence; 60-Day Proof.
• Weeks 1–2: bills, feeder map, cleanroom constraints, security path.
• Weeks 3–8: weekly ranked cards; WhatsApp to Ramniwas / HVAC owner.
• Weeks 9–12: verify with evidence; optional DISCOM line.
• Success: one owned action with defensible ₹ movement.
• Kill: chosen meter below commercial floor; no plant sponsor; no data path in 14 days; demand for 15-plant SOW; IR-only conversation.

4.6 Concern scores (1–10) and who owns them (mandatory from Aug 2026)

Score this Faridabad cluster, not “medtech in general.” 10 = weekly C-suite / plant-head issue.

4.7 Pitch sketches (draft — human will refine)

1. P&L / bill (K.L. Gupta): Your Faridabad plots sit on DHBVN with cleanroom air that does not sleep when a line pauses. We sit read-only on the existing meters, put a rupee on which chiller bank or moulding start drove MD, assign it on WhatsApp, and keep the outcome verified with evidence on our ledger. 60-Day Proof on one feeder. Two redacted bills to see if the band is even worth a paid run. Solar stays; this is the operating remainder.

2. Maintenance (Ramniwas / HVAC): This is not an energy-manager job. It is fewer 2 a.m. chiller and compressor calls, and a clearer idle-off list that does not fight AHU interlocks. We do not write to PLCs. You execute stagger and idle; we show ₹ and evidence. Kartar’s old utility map (chillers, WFI, air, HT/LT) is the worklist.

3. Production: We will not touch validated cycle times or cleanroom pressure. The Rx is sequencing starts and cutting idle utilities in confirmed no-batch windows so OEE is not the bill’s enemy. If a card fights dispatch, it dies.

5. Before you reach out

Faridabad visit math: Sector 59 HSIIDC is already on the LNM route. Do not open as investor relations. Do not open as ESG. Open as one plot’s DHBVN peak.

5.1 Discovery checklist

• Confirm legal name on DHBVN invoice = Poly Medicure Limited (or exact consuming affiliate)
• Which HT is larger: Sector 59 104-105 vs 115-116 vs 117 vs IMT 33-34
• Two recent HT bills: ₹ total, MD, PF, ToD, contract demand — ₹15–40 lakh/month [~] cluster hypothesis
• Chillers / WFI / moulding on the same incomer?
• Rooftop vs AMPIN PPA settlement on this plot
• Gamma / ETO on this meter?
• Name of production GM under K.L. Gupta
• WhatsApp owner for maintenance cards (Ramniwas vs shift)
• NDA / vendor registration path
• Do not use investorcare@ as a personal greeting to Himanshu
• Confirm kl.gupta@polymedicure.com before a second mail if bounce

5.2 Do not lead with

• Do not lead with dashboards, AI, digital twin, or group Industry 4.0
• Do not lead with ESG / net-zero 2050 / “next DISCOM bill” as the hero — lead with verified with evidence
• Do not lead with LNM as a comparable logo
• Do not promise Band A fees on a single light plot
• Do not propose HVAC setpoint cuts that threaten ISO 13485 environment

5.3 Opening hooks (email / call / WhatsApp)

• “Sector 59 / IMT — which chiller bank is on the DHBVN peak?”
• “Read-only on one Polymed HT: cleanroom air vs moulding start, rupees on WhatsApp, verified with evidence. 60-Day Proof.”

6. Risks, flags, controversies & sources

6.1 Integrity / controversy / regulatory (search explicitly)

Searched (Aug 2026): Poly Medicure / Polymed + Faridabad + NGT, HSPCB, lawsuit, fraud, labour, tax raid, pollution, recall.

• Stamp duty order 15 Jun 2026: Delhi Revenue ₹2.5 Cr (₹1.00 Cr deficit + ₹1.50 Cr penalty) on 2021–2024 share allotments. Company says duty already paid via depositories and is contesting. Not a plant pollution story. Cite as a live legal/IR item; do not moralise.
• Trademark: Poly Medicure vs Polybond India (Delhi HC, 2019, POLYSURE) — ordinary IP dispute, old.
• NGT / Faridabad units 2025–26: broad HSPCB delay stories on illegal metal units. Polymed not identified as a named respondent in searches run here; some neighbourhood noise/vibration items treat them as a complainant. Do not attach generic Faridabad NGT dockets to Polymed.
• POSH / labour: AR discloses ICC compliance; FY26 extra-ordinary ₹6.8 Cr labour-code gratuity provision — accounting, not a raid.
• Product recalls / CDSCO: none found in this pass. Absence ≠ clearance.

None found for fraud, tax raid, or promoter criminality in reviewed sources.

6.2 Data quality flags

• CIN in some briefs (…067008) is wrong; use L40300DL1995PLC066923
• Bill band is cluster [~], not a meter fact
• Group moulding/assembly counts ≠ Sector 59 counts
• BRSR GJ ≠ Faridabad ₹
• kl.gupta@ inferred from pattern info@ / cs@ / investorcare@ on polymedicure.com — confirm
• Kartar is former (May 2026)
• Palwal is FY27, not a 2026 visit plant
• FY26 consol includes European acquisitions — do not use consol growth as Faridabad load growth

6.3 Sources consulted

• https://www.polymedicure.com
• AR FY24-25 / AGM notice (BSE / Business Standard republication) — CIN, plants, employees 3,082, AMPIN JV, emails
• IR Q1 FY26 (8 Aug 2025) and Q4 & FY26 (25 May 2026) — geo mix, 15 plants, machine counts, Palwal FY27, capex ₹296 Cr FY26
• Medgate / results commentary — ₹325 Cr capex FY25
• BRSR FY24-25 — energy GJ, ISO 9001/13485/14001, PAT No, 9.9 MWp PPA, ISO 50001 absent
• ScanX — stamp duty order Jun 2026
• LexTechSuite — Polybond trademark 2019
• LinkedIn: K.L. Gupta, Himanshu Baid, Ramniwas Pal, Abhit Kumar Gupta, Rahul Dev Bhardwaj, Kartar Singh Rawat
• Company LinkedIn https://www.linkedin.com/company/poly-medicure-ltd
• Stamped ICP v2; messaging canon; Faridabad DHBVN context
• leads/lead-research-master-company-index.md — not listed (net-new)